PolyPid Ltd. (PYPD)
NASDAQ·Healthcare·Biotechnology
$6.14
+0.00%
Mkt Cap $42.60M
Analyst Ratings
No recent rating data.
Price Target (5 analysts)
$11.67
Range $10.00 – $13.00
Implied Upside
+90.1%
Consensus $11.67 vs current $6.14
NASDAQ·Healthcare·Biotechnology
$6.14
+0.00%
Mkt Cap $42.60M
No recent rating data.
Price Target (5 analysts)
$11.67
Range $10.00 – $13.00
+90.1%
Consensus $11.67 vs current $6.14